Loader

Pathways

PathWhiz ID Pathway Meta Data

PW146999

Pw146999 View Pathway
metabolic

Clorazepate Drug Metabolism Pathway

Homo sapiens

PW127704

Pw127704 View Pathway
drug action

Clorazepic Acid Action Pathway

Homo sapiens
Clorazepic acid or clorazepate is a benzodiazepine used to treat anxiety, partial seizures, and alcohol withdrawal. Clorazepate is indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. It is also used as adjunctive therapy in the management of partial seizures and for the symptomatic relief of acute alcohol withdrawal. Clorazepate is a benzodiazepine with depressant effects on the central nervous system.8 Benzodiazepines are able to enhance the binding of gamma-aminobutyric acid (GABA) to the GABA type A (GABA-A) receptor by binding to a region in the extracellular domain found at the interface between the alpha (α) and gamma (γ) subunits of the GABA-A receptor. The interaction of GABA and the GABA-A receptor promotes channel opening, leading to an increased chloride influx. Consequently, the use of benzodiazepines, such as clorazepate, leads to neuronal hyperpolarization. Clorazepate is a prodrug for nordiazepam which is converted in the liver. Some side effects of using clorazepic acid may include dizziness, nervousness, blurred vision, and headache.

PW176011

Pw176011 View Pathway
metabolic

Clorazepic acid Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Clorazepic acid are predicted with biotransformer.

PW132553

Pw132553 View Pathway
metabolic

Clothiapine Drug Metabolism

Homo sapiens
Clothiapine is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Clothiapine passes through the liver and is then excreted from the body mainly through the kidney.

PW146623

Pw146623 View Pathway
drug action

Clothiapine Drug Metabolism Action Pathway

Homo sapiens

PW127706

Pw127706 View Pathway
drug action

Clotiazepam Action Pathway

Homo sapiens
Clotiazepam is a thienodiazepine used to manage anxiety disorders and insomnia. Clotiazepam (marketed under brand name Clozan, Distensan, Trecalmo, Rize, Rizen and Veratran) is a thienodiazepine drug which is a benzodiazepine analog. Clotiazepam binds to the benzodiazepine site of the GABAA receptor where it acts as a full agonist; this action results in an enhanced GABA inhibitory effect at the GABAA receptor which results in the pharmacological effects of clotiazepam. Clotiazepam acts at the benzodiazepine receptors (BZD). This agonizes the action of GABA, increasing the frequency of opening of the channel chlorinates and penetration of the ions chlorinates through the ionophore. Increase in membrane polarization decreases the probability of discharge of neurons. Some side effects of using Clotiazepam may include drowsiness, lightheadedness, and vertigo.

PW145444

Pw145444 View Pathway
drug action

Clotiazepam Drug Metabolism Action Pathway

Homo sapiens

PW126641

Pw126641 View Pathway
drug action

Clotrimazole Action Pathway

Homo sapiens
Clotrimazole is an anti-fungal drug that is typically applied topically in the form of a cream. It can also be taken as a troche formulation (a tablet that dissolves on your tongue) for throat infections. It has also become a drug of interest in treating sickle cell disease, malaria, and some cancers. More research is needed for that. Clortrimazole is used for fungal infections caused by Candida albicans or Malassezia furfur. Once Clotrimazole is applied to the infected area, such as the skin, it enters the infected cells by way of the transporter P-glycoprotein. Once in the infected cell it targets Lanosterol 14-alpha demethylase, a cytochrome enzyme, and inhibits it. Lanosterol 14-alpha demethylase catalyzes Lanosterol into 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol which is used in ergosterol biosynthesis. Ergosterol is essential for cell membrane stability and synthesis. Clotrimazole also inhibits Ergosterol itself by binding to it in the cell membrane, creating a transmembrane channel that increases cell permiability allowing leakage of cellular components. Eventually this compromises cell integrity and causes cell death. The fungal cell also cannot synthesize new bud membranes to make new cells. Clotrimazole also inhibits Intermediate conductance calcium-activated potassium channel protein 4 which is present in non-excitable cells of homo sapiens. This channel releases potassium from the cell when calcium enters in order to keep non-excitable cells polarized. The blocking of this channel means that when calcium enters the cell, potassium cannot leave the cell and hypopolarization or depolarization occurs in the cell. This depolarization would have many unknown effects on the cell as many compounds and enzymes in the cell require certain polarization to function properly. Clotrimazole is a partial agonist to Hydroxycarboxylic acid receptor 2 on adipose cells or possibly the spleen if it were to reach the spleen. Hydroxycarboxylic acid receptor 2 is a receptor that releases adiponectin. Adiponectin is a fat-derived hormone that causes insulin resistance in the liver and skeletal muscles, therefore Clotrimazole causes a partial inhibition of the insulin pathway. Hydroxycarboxylic acid receptor 2 also inhibits the enzyme anenylyl cyclase which is the enzyme that makes cAMP from ATP. cAMP is essential for lypolysis which is the synthesis of glycerol and 3-fatty acids. The Hydroxycarboxylic acid receptor has a high affinity for (D)-beta-hydroxybutyrate and nicotinic acid, but only in high enough doses that are not present in the human body. Therefore this receptor can only be activated by drugs such as Clotrimazole.

PW132443

Pw132443 View Pathway
metabolic

Clotrimazole Drug Metabolism

Homo sapiens
Clotrimazole is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Clotrimazole passes through the liver and is then excreted from the body mainly through the kidney.

PW144386

Pw144386 View Pathway
drug action

Clotrimazole Drug Metabolism Action Pathway

Homo sapiens